Nuvectis Pharma Inc.

NVCT | NASDAQ

Price Alert Chart Builder DCF Calculator

$21.98

-$0.02 (-0.09%)

At close: Sep 21, 2026, 4:00 PM ET

$21.98

$0 (0.00%)

After-hours: Sep 21, 2026, 4:10 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-0.09%

(1D)

Rating

Updated: Aug 12, 2026

18.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $583.27M

1D Range

21.64 22.28

52W Range

5.55 29.28

Valuation (TTM)

PE -16.78

PB 64.22

EV/EBITDA -19.40

Valuation (NTM)

Forward PE N/A

Forward PEG -1.62

Price Target $37.33

Cash Flow

FCF Yield -4.5%

SBC Adj. FCF Yield -5.9%

SBC Impact -32.1%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y -0.4% | 1.5%

FCF 3Y | 5Y -32.8% | -15.7%

Returns

ROA -124.5%

ROE -169.5%

ROIC -317.9%

Financial Health

Net Cash

$22.16M

Current Ratio 1.68

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Nuvectis Pharma, Inc. operates as a biopharmaceutical firm specializing in the development of targeted therapies to address critical, unmet needs within the field of oncology. The company's innovative...

Sector Healthcare

Industry Biotechnology

Employees 16

IPO Date Feb 3, 2022

Website www.nuvectis.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$39

Upside

+77.43%

Buy (2)

Hold (0)

Sell (0)

Analyst Details ➞